H 963 Massachusetts House · 193rd Legislature (2023-2024)

An Act relative to costs for treatment and management of diabetes

This bill limits the out-of-pocket costs that health insurance plans in Massachusetts must charge for diabetes-related medications. It directly affects people with diabetes and the insurance companies that cover their treatment. Under the new rules, plans cannot charge more than $25 for a 30-day supply of insulin, $50 for oral diabetes medications, or $100 for other covered diabetes items. These cost caps apply across various types of health insurance, including private plans, Medicaid, and other state-regulated coverage.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2024
Senate Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action May 9, 2024
Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
2
Feb 22, 2024
Committee
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Feb 16, 2023
Upper · Passed
Senate concurred
upper
Feb 16, 2023
Committee
Referred to the committee on Financial Services
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Pete Capano
Pete Capano
DDemocratic
MA
11th Essex